hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06264830, orgStudyIdInfo id: 202307103DIPC, briefTitle: 3D Visualization System in Highly Myopic Cataract Operation, acronym: 3D-HiMCO, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: National Taiwan University Hospital, class: OTHER, collaborators name: Alcon Research, descriptionModule briefSummary: This study aims to investigate the impact of depth of field differences between the use of the 3D imaging system (NGENUITY® 3D Visualization System, Alcon, TX, USA) and conventional optical microscope in cataract surgery for highly myopic patients on intraoperative parameters and outcomes., conditionsModule conditions: Cataract, conditions: High Myopia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 45, type: ESTIMATED, armsInterventionsModule interventions name: Alcon-NGENUITY®(NG)-system, interventions name: Standard cataract operation, outcomesModule primaryOutcomes measure: Number of times of Microscopic focus adjustment, measured by counting from the video recordings, primaryOutcomes measure: Total moving distance in millimeter of microscope-lens-system relative to suspension arm, measured by ruler set on microscope, primaryOutcomes measure: Distance of subjective focus change in millimeter between corneal surface and surface of posterior capsule, measured by ruler set on microscope, secondaryOutcomes measure: Total operation time, secondaryOutcomes measure: Cumulative dissipated energy (CDE) of phacoemulsification, that is automatically measured and demonstrated on the screen of phacoemulsification machine (Centurion), secondaryOutcomes measure: Number of Participants with intraoperative complication, secondaryOutcomes measure: Best-corrected visual acuity of the operated eye of Participants at each postoperative follow-up within 3 month, measured with Snellen chart under standard condition (6 meters in distance and standard illumination of environment), secondaryOutcomes measure: Number of Participants with post-operative complication, secondaryOutcomes measure: Intraocular pressure of the operated eye of participants at each postoperative follow-up within 3 month, measured with pneumatic tonometer, eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Department of Ophthalmology, National Taiwan University Hospital, city: Taipei, zip: 100, country: Taiwan, contacts name: Tzyy-Chang Ho, MD, role: CONTACT, phone: 886-2-23123456, phoneExt: 62579, email: hotc@ntuh.gov.tw, contacts name: Cheng-Yung Lee, MD, role: CONTACT, phone: 886-2-23123456, phoneExt: 65190, email: G05875@hch.gov.tw, geoPoint lat: 25.04776, lon: 121.53185, hasResults: False
protocolSection identificationModule nctId: NCT06264817, orgStudyIdInfo id: EC 48 LyberT, briefTitle: Auto-Adjustable MOBIDERm Autofit Armsleeve in the Management of Upper Limb Lymphedema., acronym: LyberT, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2025-03-15, completionDateStruct date: 2025-04-15, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Thuasne, class: INDUSTRY, descriptionModule briefSummary: This study aims to assess Auto-Adjustable MOBIDERM® Autofit Armsleeve effect on upper limb volume excess compared to the compression bandages to manage the volume of upper limb lymphedema in patients with breast cancer related lymphedema, conditionsModule conditions: Lymphedema of Upper Limb, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Prospective, multi-center, interventional, controlled-randomized, single blinded study, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: For the same patient, all measurements will be performed as far as possible by the same health professional who doesn't have the knowledge of patient's group., whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: MOBIDERM Autofit Armsleeve, interventions name: Compressive bandaging, outcomesModule primaryOutcomes measure: Volume excess variation, secondaryOutcomes measure: Resource consumption, secondaryOutcomes measure: Resource consumption, secondaryOutcomes measure: Resource consumption, secondaryOutcomes measure: Lymphedema related Quality of life (QoL), secondaryOutcomes measure: Doctors' opinion on improving the patient's health condition, secondaryOutcomes measure: Patient's opinion on Global Impression of Change, secondaryOutcomes measure: Satisfaction about the device, secondaryOutcomes measure: The safety, secondaryOutcomes measure: Compliance to treatment, secondaryOutcomes measure: General quality of life (QoL), secondaryOutcomes measure: Skin elasticity, secondaryOutcomes measure: Ttissue induration, eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Pinar BORMAN, city: Ankara, country: Turkey, contacts name: Pinar BORMAN, role: CONTACT, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06264804, orgStudyIdInfo id: [2023] No. 86, briefTitle: Risk Factors for Progressive Suction Loss in Corneal Refractive Surgery, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-16, primaryCompletionDateStruct date: 2024-07-01, completionDateStruct date: 2024-12-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Yifeng Yu, class: OTHER, descriptionModule briefSummary: The goal of this Prospective observational studiesis to Characteristics of progressive suction loss., conditionsModule conditions: Refractive Surgery, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: PROSPECTIVE, enrollmentInfo count: 800, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Identify risk factors for progressive suction loss, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Yuyifeng, status: RECRUITING, city: Nanchang, state: Jiangxi, zip: 330008, country: China, contacts name: yifeng Yu, Doctorate, role: CONTACT, phone: +8613979180258, email: 171018170@qq.com, geoPoint lat: 28.68396, lon: 115.85306, hasResults: False
protocolSection identificationModule nctId: NCT06264791, orgStudyIdInfo id: STUDY00018516, secondaryIdInfos id: K99AA030591, type: NIH, link: https://reporter.nih.gov/quickSearch/K99AA030591, briefTitle: Stress-motivated Alcohol Use as a Value-based Decision-making Process, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2024-10-01, completionDateStruct date: 2024-10-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: University of Washington, class: OTHER, collaborators name: National Institute on Alcohol Abuse and Alcoholism (NIAAA), descriptionModule briefSummary: The goal of this experimental study is to improve our understanding of the effects of stress on the decision to consume (more) alcohol in regular drinkers. The main question\[s\] it aims to answer are:* Does psychological stress affect the decision to consume (more) alcohol?* How does psychological stress affect the decision to consume (more) alcohol? Participants will be randomly assigned to one of four conditions (stress alcohol, stress no alcohol, no stress alcohol, no stress no alcohol) and complete a value-based decision-making task twice (once before and once after the manipulations)., conditionsModule conditions: Psychological Stress, conditions: Alcohol Intoxication, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: FACTORIAL, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: NONE, enrollmentInfo count: 160, type: ESTIMATED, armsInterventionsModule interventions name: Stress, interventions name: Alcohol, outcomesModule primaryOutcomes measure: Proportion of choices for alcoholic over non-alcoholic drinks., eligibilityModule sex: ALL, minimumAge: 21 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Washington, status: RECRUITING, city: Seattle, state: Washington, zip: 98105, country: United States, contacts name: Jonas Dora, PhD, role: CONTACT, phone: 206-741-6330, email: jdora@uw.edu, geoPoint lat: 47.60621, lon: -122.33207, hasResults: False
protocolSection identificationModule nctId: NCT06264778, orgStudyIdInfo id: 2023013, briefTitle: Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2025-11-01, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Shandong University, class: OTHER, descriptionModule briefSummary: This pilot clinical trial plans to carry out dabrafenib adjuvant therapy combined with lesion curettage after fenestrated decompressive surgery for BRAF mutation-positive multicystic ameloblastoma to explore the effectiveness of this therapy in preventing tumor recurrence, reducing or even avoiding postoperative deformity and dysfunction. effect. Based on this, we plan to launch a prospective clinical study of dabrafenib in the treatment of BRAF V600E ameloblastoma, verify the feasibility of drug treatment or drug-assisted treatment of ameloblastoma, and provide patients with a safer Effective new treatment options will benefit more patients., conditionsModule conditions: Ameloblastoma, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: This study is a single-arm study that does not involve randomization or blinding, nor does it establish a parallel control group and uses external control., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: Dabrafenib, outcomesModule primaryOutcomes measure: objective response rate, secondaryOutcomes measure: Relapse-free survival, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06264765, orgStudyIdInfo id: 22-12-23, briefTitle: Scalp Block -Craniotomi, acronym: scalp block, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2025-01-01, completionDateStruct date: 2026-01-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Aydin Adnan Menderes University, class: OTHER, descriptionModule briefSummary: Postoperative pain after craniotomy is an important clinical problem as it can lead to hypertension and increased intracranial pressure. Multimodal analgesia methods are performed by anesthesiologists in different ways depending on the anesthetist's preference.In addition, both techniques have been shown in studies to provide intraoperative hemodynamic stabilization in addition to their effects on postoperative pain. Although there are many studies on both techniques, the number of studies comparing scalp block with infiltration technique is very limited. Therefore, postoperative use of scalp block and incisional infiltration for postoperative pain after craniotomy is recommended., conditionsModule conditions: Hemodynamic Instability, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: randomized double blinding, primaryPurpose: OTHER, maskingInfo masking: DOUBLE, maskingDescription: Blind patients and postoperative follow-ups will not know which group the patient is in the study., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, enrollmentInfo count: 62, type: ESTIMATED, armsInterventionsModule interventions name: scalp block, interventions name: Incisional infiltration, outcomesModule primaryOutcomes measure: opioid consumption, secondaryOutcomes measure: The Numeric Rating Scale (NRS), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ferdi Gülaştı, status: RECRUITING, city: Aydın, zip: 09020, country: Turkey, contacts name: Ferdi Gülaştı, role: CONTACT, email: ferdigulasti@gmail.com, geoPoint lat: 37.84501, lon: 27.83963, hasResults: False
protocolSection identificationModule nctId: NCT06264739, orgStudyIdInfo id: 22-12-23/2, briefTitle: Erector Spinae Block -Dexmedetomidine, acronym: esp -dex, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2025-01-01, completionDateStruct date: 2026-01-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Aydin Adnan Menderes University, class: OTHER, descriptionModule briefSummary: Postoperative pain is common after spinal surgeries, including lumbar disc surgery. Surgical anesthesia and perioperative analgesic regimen are aimed at complete intraoperative amnesia, deep analgesia, effective control of autonomic responses and rapid discharge from the hospital.Although there are many studies on the use of these techniques for postoperative analgesia, the number of data comparing these techniques that can be used in meta-analyses is low. In our study, investigators aimed to compare the effects of remifentanil and dexmedetomidine accompanied by ESP block, which are different multimodal analgesia methods, on pain., conditionsModule conditions: Postoperative Acute Pain, conditions: Opioid Consumption, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: randomized double blinding, primaryPurpose: OTHER, maskingInfo masking: DOUBLE, maskingDescription: Blindness patients and those who follow up after surgery will not know which group is in the study., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, enrollmentInfo count: 74, type: ESTIMATED, armsInterventionsModule interventions name: esp Dexmedetomidine (dekstomid), interventions name: esp remifentanyl (ultiva), outcomesModule primaryOutcomes measure: opioid consumption, secondaryOutcomes measure: The Numeric Rating Scale (NRS), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ferdi Gülaştı, status: RECRUITING, city: Aydın, zip: 09020, country: Turkey, contacts name: Ferdi Gülaştı, role: CONTACT, email: ferdigulasti@gmail.com, geoPoint lat: 37.84501, lon: 27.83963, hasResults: False
protocolSection identificationModule nctId: NCT06264726, orgStudyIdInfo id: 23-0254, secondaryIdInfos id: R01HL150909, type: NIH, link: https://reporter.nih.gov/quickSearch/R01HL150909, briefTitle: CommunityRx-Cardiovascular Disease, acronym: CRx-CVD, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-12, primaryCompletionDateStruct date: 2025-03-12, completionDateStruct date: 2025-03-12, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: University of North Carolina, Chapel Hill, class: OTHER, collaborators name: National Heart, Lung, and Blood Institute (NHLBI), descriptionModule briefSummary: The goal of this single arm pre-test post-test design study is to test the impact of providing patients with information about community-based resources to address health-related social needs and cardiometabolic health in rural African American patients. The main question it aims to answer is:• What is the effectiveness of community resource information on patient self-efficacy to use community resources?Participants will be given:* A personalized "HealtheRx" resource with information about community resources related to food, housing, utility support, transportation, and crisis support. The HealtheRx is personalized for patients based on their age and zip code.* Access to a community resource navigator for support with using the HealtheRx upon request* 2 text messages with reminders about the HealtheRx and access to the community resource navigator, conditionsModule conditions: Cardiovascular Diseases, conditions: Self Efficacy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 325, type: ESTIMATED, armsInterventionsModule interventions name: HealtheRx, outcomesModule primaryOutcomes measure: Change in participant self-efficacy for finding community resources, secondaryOutcomes measure: Change in participant knowledge of community resources, secondaryOutcomes measure: Change in participant utilization of community resources, eligibilityModule sex: ALL, minimumAge: 2 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: OIC Family Medical Center - Fairview, status: RECRUITING, city: Rocky Mount, state: North Carolina, zip: 27801, country: United States, contacts name: Jesslyn Pope, role: CONTACT, email: jpope@oicone.org, geoPoint lat: 35.93821, lon: -77.79053, locations facility: OIC Family Medical Center - Happy Hill, status: RECRUITING, city: Rocky Mount, state: North Carolina, zip: 27804, country: United States, contacts name: Jesslyn Pope, role: CONTACT, email: jpope@oicone.org, geoPoint lat: 35.93821, lon: -77.79053, hasResults: False
protocolSection identificationModule nctId: NCT06264687, orgStudyIdInfo id: HepcidinIVIron, briefTitle: Hepcidin After Intravenous Iron Treatment, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-05-31, completionDateStruct date: 2024-05-31, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Pierre-Alexandre Krayenbühl, class: OTHER, descriptionModule briefSummary: The aim of this study is to investigate the hepcidin hormone response after intravenous iron administration., conditionsModule conditions: Iron Deficiency (Without Anemia), designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 10, type: ESTIMATED, outcomesModule primaryOutcomes measure: Serum Hepcidin Change, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06264661, orgStudyIdInfo id: HJM 006/22-R, briefTitle: Effect of Cognitive Behavioral Therapy and Phototherapy on Glycosylated Hemoglobin, CLOCK Genes and Quality of Life in Patients With Type 2 Diabetes Mellitus and Insomnia, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-08-08, primaryCompletionDateStruct date: 2022-09-30, completionDateStruct date: 2022-11-30, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Centro Interdisciplinario de Ciencias de la Salud Unidad Santo Tomás, class: OTHER, descriptionModule briefSummary: Purpose: To analyze the efficiency of Cognitive Behavioral Intervention in combination with phototherapy to reduce insomnia and improve glycemic control, quality of life, and CLOCK genes expression in patients with type 2 diabetes mellitus. Methods: Clinical, quasi-experimental, pre-post, explanatory, non-probability sampling. Subjects were invited to participate in Hospital Juárez de México. They received eight sessions of Cognitive Behavioral Therapy in combination with phototherapy. The assessment was carried out with validated instruments for Mexican population and gene expression was evaluated by real-time PCR., conditionsModule conditions: Type 2 Diabetes, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: SINGLE_GROUP, interventionModelDescription: Clinical, quasi-experimental, pre-post, explanatory, non-probability sampling. Subjects were invited to participate in Hospital Juárez de México. They received eight sessions of Cognitive Behavioral Therapy in combination with phototherapy. The assessment was carried outwith validated instruments for Mexican population and gene expression was evaluated by real-time PCR., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 23, type: ACTUAL, armsInterventionsModule interventions name: Effect of Cognitive Behavioral Therapy with Phototherapy in glycated hemoglobin, CLOCK genes and quality of life in patients with type 2 diabetes mellitus and insomnia, outcomesModule primaryOutcomes measure: Sleep quality, primaryOutcomes measure: Glycosylated hemoglobin, primaryOutcomes measure: Quality of life, primaryOutcomes measure: Insomnia, secondaryOutcomes measure: Gene expression analysis of CLOCK, secondaryOutcomes measure: Gene expression analysis of BMAL1, secondaryOutcomes measure: Gene expression analysis of PER1, secondaryOutcomes measure: Gene expression analysis of PER2, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Centro Interdisciplinario de Ciencias de la Salud Unidad Santo Tomás, city: Cdmx, state: México, zip: 11360, country: Mexico, hasResults: False
protocolSection identificationModule nctId: NCT06264648, orgStudyIdInfo id: AIBU-FTR-OOP-04, briefTitle: Investigation of Palpation Pressure Sensitivity, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-05-03, primaryCompletionDateStruct date: 2023-06-16, completionDateStruct date: 2023-10-20, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Abant Izzet Baysal University, class: OTHER, descriptionModule briefSummary: The study is planned for searching physiotherapists palpation abilities. There were 2 groups of physiotherapists. They were asked for to push target pressures. After making some exercise, the assesment was done again., conditionsModule conditions: Sensitivity Training Groups, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: 2 groups of physiotherapists with different fields of experience were attended to study., primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 63, type: ACTUAL, armsInterventionsModule interventions name: Pressure sensitivity education, outcomesModule primaryOutcomes measure: Measurement Palpation Pressure with Digital Scale, primaryOutcomes measure: Measurement Palpation Pressure with Digital Scale, eligibilityModule sex: ALL, minimumAge: 22 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Faculty of Health Sciences Bolu Abant İzzet Baysal University, city: Bolu, zip: 14300, country: Turkey, geoPoint lat: 40.73583, lon: 31.60611, hasResults: False